Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer
- PMID: 32449246
- PMCID: PMC7385389
- DOI: 10.1111/cas.14500
Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer
Abstract
The frequency of microsatellite instability (MSI) is reportedly extremely low in breast cancer, despite widespread clinical expectations that many patients would be responsive to immune-checkpoint inhibitors (ICI). Considering that some triple-negative breast cancers (TNBC) responded well to ICI in a clinical trial and that a high density of tumor-infiltrating lymphocytes (TILs) is frequently observed in other cancers with high levels of microsatellite instability (MSI-H), we hypothesized that some TNBC with a high density of TILs would be MSI-H. Medullary carcinoma (MedCa) of the breast, a rare histological type, is characterized by a high density of TILs. Considering that MedCa of the colon is often MSI-H, we suspected that MedCa in breast cancer might also include MSI-H tumors. Therefore, we conducted MSI tests on such breast cancers with a high density of TILs. The MSI status of 63 TIL-high TNBC and 38 MedCa tumors, all from Asian women who had undergone curative surgery, were determined retrospectively. DNA mismatch repair (MMR) proteins and PD-L1 expression were also investigated immunohistochemically. All samples were microsatellite stable, being negative for all microsatellite markers. TIL-high TNBC with low MLH1 protein had higher levels of PD-L1 in stromal immune cells (P = .041). MedCa tumors showed significantly higher PD-L1 expression in immune cells than in TIL-high TNBC (<.001). We found that MSI-H tumors were absent in TIL-high breast cancers. Examination of MMR proteins, not a purpose of Lynch syndrome screening, may merit further studies to yield predictive information for identifying patients who are likely to benefit from ICI.
Keywords: DNA mismatch repair protein; PD-L1; breast cancer; medullary carcinoma; microsatellite instability; tumor-infiltrating lymphocyte.
© 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures

Similar articles
-
Triple-Negative Breast Cancer: Intact Mismatch Repair and Partial Co-Expression of PD-L1 and LAG-3.Front Immunol. 2021 Feb 24;12:561793. doi: 10.3389/fimmu.2021.561793. eCollection 2021. Front Immunol. 2021. PMID: 33717059 Free PMC article.
-
Molecular Characteristics of Lymphocyte-predominant Triple-negative Breast Cancer.Anticancer Res. 2021 Apr;41(4):2133-2140. doi: 10.21873/anticanres.14985. Anticancer Res. 2021. PMID: 33813424
-
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes.Oncologist. 2020 Jun;25(6):481-487. doi: 10.1634/theoncologist.2019-0611. Epub 2020 Jan 22. Oncologist. 2020. PMID: 31967692 Free PMC article.
-
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.Ann Oncol. 2019 Aug 1;30(8):1232-1243. doi: 10.1093/annonc/mdz116. Ann Oncol. 2019. PMID: 31056702
-
Identification and Utilization of Biomarkers to Predict Response to Immune Checkpoint Inhibitors.AAPS J. 2020 Oct 14;22(6):132. doi: 10.1208/s12248-020-00514-4. AAPS J. 2020. PMID: 33057937 Review.
Cited by
-
Molecular pathology in breast disease: diagnostic, prognostic, and therapeutic tools.Virchows Arch. 2024 Feb;484(2):247-261. doi: 10.1007/s00428-023-03709-0. Epub 2023 Nov 28. Virchows Arch. 2024. PMID: 38015260 Free PMC article. Review.
-
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization.Cancer Cell Int. 2021 May 17;21(1):266. doi: 10.1186/s12935-021-01976-y. Cancer Cell Int. 2021. PMID: 34001143 Free PMC article. Review.
-
DNA Mismatch Repair System Imbalances in Breast Adenocarcinoma.Cancer Diagn Progn. 2023 Mar 3;3(2):169-174. doi: 10.21873/cdp.10197. eCollection 2023 Mar-Apr. Cancer Diagn Progn. 2023. PMID: 36875308 Free PMC article. Review.
-
Commentary: Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients.Front Oncol. 2021 Sep 29;11:735476. doi: 10.3389/fonc.2021.735476. eCollection 2021. Front Oncol. 2021. PMID: 34660298 Free PMC article. No abstract available.
-
Targeting Neoantigens in Cancer: Possibilities and Opportunities in Breast Cancer.Antibodies (Basel). 2024 Jun 10;13(2):46. doi: 10.3390/antib13020046. Antibodies (Basel). 2024. PMID: 38920970 Free PMC article. Review.
References
-
- Hampel H, Frankel W, Panescu J, et al. Screening for lynch syndrome (Hereditary Nonpolyposis Colorectal Cancer) among endometrial cancer patients. Cancer Res. 2006;66:7810‐7817. - PubMed
-
- Hause RJ, Pritchard CC, Shendure J, et al. Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016;22:1342. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials